escitalopram
Selected indexed studies
- Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders: A Randomized Clinical Trial. (JAMA Psychiatry, 2023) [PMID:36350591]
- The clinical pharmacokinetics of escitalopram. (Clin Pharmacokinet, 2007) [PMID:17375980]
- Escitalopram versus other antidepressive agents for major depressive disorder: a systematic review and meta-analysis. (BMC Psychiatry, 2023) [PMID:38001423]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders: A Randomized Clinical Trial. (2023) pubmed
- Escitalopram versus other antidepressive agents for major depressive disorder: a systematic review and meta-analysis. (2023) pubmed
- The clinical pharmacokinetics of escitalopram. (2007) pubmed
- The safety and efficacy of escitalopram and sertraline in post-stroke depression: a randomized controlled trial. (2024) pubmed
- Escitalopram for agitation in Alzheimer's dementia: a randomized controlled phase 3 trial. (2025) pubmed
- Escitalopram-associated rhabdomyolysis. (2023) pubmed
- Escitalopram. (2026) pubmed
- Escitalopram Personalized Dosing: A Population Pharmacokinetics Repository Method. (2023) pubmed
- Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis. (2024) pubmed
- Mindfulness Meditation vs Escitalopram for Treatment of Anxiety Disorders: Secondary Analysis of a Randomized Clinical Trial. (2024) pubmed